The predictive but not prognostic value of MGMT promoter methylation status in elderly glioblastoma patients: a meta-analysis.
about
DNA methylation biomarkers: cancer and beyondTemozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 ExpressionGene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patientsManagement of elderly patients with gliomasInvestigating molecular alterations to profile short- and long-term recurrence-free survival in patients with primary glioblastoma.DNA methylation profiles in cancer diagnosis and therapeutics.The prognosis of MGMT promoter methylation in glioblastoma patients of different race: a meta-analysis.Glioblastoma Treatment in the Elderly.Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?BICD1 expression, as a potential biomarker for prognosis and predicting response to therapy in patients with glioblastomas.The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma.The Clinical Significance of O6-Methylguanine-DNA Methyltransferase Promoter Methylation Status in Adult Patients With Glioblastoma: A Meta-analysis.A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma.
P2860
Q26996421-04816F8E-D3F4-4BFD-B9FA-D7D8C3C35ADDQ28550138-1D00EDD8-D3C5-45D6-966C-3343B00C9B6AQ34117487-47769D99-EE1B-42E1-AEDD-4A64D22E0529Q34641001-E62CD9C5-F73D-4A13-B1E1-2CF7DAD451D7Q36335681-27C42776-1660-4C90-A84E-1EF71C50061FQ38650593-642935B9-D7F3-4757-BB57-E8F9A78244E6Q45835773-936B974E-5E16-43B8-B831-6A41A39493E4Q47107733-35B2E9E0-8055-4DDF-B7EF-0EA42E0C7709Q48097278-508033D0-24DF-4CAF-A4E2-EE441CA98F7BQ49640790-E85E6AAD-E406-49D3-B2C8-391C43A779E4Q51746838-CA8377E9-BA5D-4239-8385-F3FF3385912FQ52606179-2633A9C8-1848-411F-AA98-4ABA66AA649BQ53698804-F4AA121D-43D8-408A-9A7D-7C0540B3E30AQ54935910-477F0229-7ED3-4C5C-A15C-53ED5B88F999
P2860
The predictive but not prognostic value of MGMT promoter methylation status in elderly glioblastoma patients: a meta-analysis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
The predictive but not prognos ...... oma patients: a meta-analysis.
@en
The predictive but not prognos ...... oma patients: a meta-analysis.
@nl
type
label
The predictive but not prognos ...... oma patients: a meta-analysis.
@en
The predictive but not prognos ...... oma patients: a meta-analysis.
@nl
prefLabel
The predictive but not prognos ...... oma patients: a meta-analysis.
@en
The predictive but not prognos ...... oma patients: a meta-analysis.
@nl
P2093
P2860
P1433
P1476
The predictive but not prognos ...... oma patients: a meta-analysis.
@en
P2093
Bo-lin Liu
Jin-xiang Cheng
Lu-hua Zhang
Xiang Zhang
P2860
P304
P356
10.1371/JOURNAL.PONE.0085102
P407
P50
P577
2014-01-13T00:00:00Z